Litcius/Paper detail

Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2

Shibo Jiang, Xiujuan Zhang, Lanying Du

2020Expert Opinion on Therapeutic Targets65 citationsDOIOpen Access PDF

Abstract

KEYWORDS: N-terminal domainreceptor-binding domainSARS-CoV-2spike proteinS2 subunittherapeutic targets

Topics & Concepts

Spike ProteinAntibodyFusion proteinSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirusCoronavirus disease 2019 (COVID-19)Spike (software development)MedicineBiologyComputational biologyImmunologyGeneticsRecombinant DNADiseaseComputer sciencePathologyInfectious disease (medical specialty)Software engineeringGeneSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studies
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2 | Litcius